Recombinant BRD7 抗体 (AA 150-200)
Our Local Distributor
北京 101111
Quick Overview for Recombinant BRD7 抗体 (AA 150-200) (ABIN7449350)
抗原
See all BRD7 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 150-200
-
原理
- Rabbit anti-BRD7 Recombinant Monoclonal Antibody [BLR220K]
-
纯化方法
- Purified
-
免疫原
- between AA 150 and 200
-
亚型
- IgG
-
-
-
-
应用备注
- 01:01,00
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 500 μg/mL
-
缓冲液
- Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- 2 - 8 °C
-
有效期
- 12 months
-
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
别名
- BRD7
-
背景
- Bromodomain-containing protein 7 was identified in a two-hybrid screen as an interactor of interferon regulatory factor-2 (IRF-2) and called CELTIX1. BRD7 was also identified as a binding partner of disheveled-1 (Dvl-1) and found to play a role in Wnt signaling and the regulation of glycogen synthase kinase 3-beta activity. Recently, BRD7 was identified as a subunit of the polybromo-associated BRG1-associated factor (PBAF) complex and shown to be required for the modulation of transcription in embryonic stem cells.
-
基因ID
- 29117
-
UniProt
- Q9NPI1
抗原
-